Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in BMJ Retrieve available abstracts of 60 articles: HTML format

Single Articles

April 2024
1. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
   Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
   BMJ. 2024;385:e076268.
   PubMed     Abstract available
   
   
   
2. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
   Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
   BMJ. 2024;385:e077209.
   PubMed     Abstract available
   
   
   March 2024
3. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
   Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
   BMJ. 2024;384:q637.
   PubMed    
   
   
   
4. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
   Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
   BMJ. 2024;384:q516.
   PubMed     Abstract available
   
   
   
5. TANNE JH
   Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
   BMJ. 2024;384:q642.
   PubMed    
   
   
   February 2024
6. 
   Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
   BMJ. 2024;384:q517.
   PubMed    
   
   
   
7. WEI Y, Feng Y, Danesh Yazdi M, Yin K, et al
   Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
   BMJ. 2024;384:e076939.
   PubMed     Abstract available
   
   
   
8. SUN Y, Milando CW, Spangler KR, Wei Y, et al
   Short term exposure to low level ambient fine particulate matter and natural cause, cardiovascular, and respiratory morbidity among US adults with health insurance: case time series study.
   BMJ. 2024;384:e076322.
   PubMed     Abstract available
   
   
   
9. KIM KS, Hong S, Han K, Park CY, et al
   Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
   BMJ. 2024;384:e076388.
   PubMed     Abstract available
   
   
   
10. MAHASE E
    Variability in blood pressure could help predict heart attack and stroke risk, researchers say.
    BMJ. 2024;384:q363.
    PubMed    
    
    
    January 2024
11. WISE J
    Early deaths from cardiovascular disease reach 14 year high in England.
    BMJ. 2024;384:q176.
    PubMed    
    
    
    
12. PHIZACKERLEY D
    Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
    BMJ. 2024;384:q53.
    PubMed    
    
    
    December 2023
13. KMIETOWICZ Z
    NICE lowers cholesterol target for people with cardiovascular disease.
    BMJ. 2023;383:p2946.
    PubMed    
    
    
    November 2023
14. GEBRE AK, Sim M, Schultz C
    Do high sensitivity cardiac troponin assays improve patient outcomes?
    BMJ. 2023;383:2741.
    PubMed    
    
    
    
15. LEE KK, Doudesis D, Ferry AV, Chapman AR, et al
    Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial.
    BMJ. 2023;383:e075009.
    PubMed     Abstract available
    
    
    
16. KHAN SU, Agarwal S, Arshad HB, Akbar UA, et al
    Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.
    BMJ. 2023;383:e077848.
    PubMed     Abstract available
    
    
    
17. WISE J
    Semaglutide reduces risk of major cardiovascular events by 20%, finds study.
    BMJ. 2023;383:p2668.
    PubMed    
    
    
    October 2023
18. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    PubMed     Abstract available
    
    
    September 2023
19. HUANG WC, Yang AS, Tsai DH, Shao SC, et al
    Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study.
    BMJ. 2023;382:e076045.
    PubMed     Abstract available
    
    
    
20. TSAI TY, Loh CH, Huang HK
    Anticholinergic medicines linked to cardiovascular events in older adults.
    BMJ. 2023;382:p2133.
    PubMed    
    
    
    
21. SELLEM L, Srour B, Javaux G, Chazelas E, et al
    Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Sante cohort: prospective cohort study.
    BMJ. 2023;382:e076058.
    PubMed     Abstract available
    
    
    August 2023
22. RAU STEUERNAGEL C, Lam CSP, Greenhalgh T
    Countering sex and gender bias in cardiovascular research requires more than equal recruitment and sex disaggregated analyses.
    BMJ. 2023;382:e075031.
    PubMed    
    
    
    
23. STURMBERG J
    Study results show vitamin D is around 99% ineffective in preventing major cardiovascular events.
    BMJ. 2023;382:p1767.
    PubMed    
    
    
    
24. SATTAR N
    There is no evidence that vitamin D prevents cardiovascular events.
    BMJ. 2023;382:p1765.
    PubMed    
    
    
    July 2023
25. RALEIGH V, Colombo F
    Cardiovascular disease should be a priority for health systems globally.
    BMJ. 2023;382:e076576.
    PubMed    
    
    
    
26. BEERSTECHER HJ
    NICE guidance on cardiovascular disease risk assessment and reduction is disappointing.
    BMJ. 2023;382:p1506.
    PubMed    
    
    
    
27. SUMMERS DJ
    Cardiovascular disease: what does QRISK actually measure?
    BMJ. 2023;382:1502.
    PubMed    
    
    
    June 2023
28. THOMPSON B, Waterhouse M, English DR, McLeod DS, et al
    Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.
    BMJ. 2023;381:e075230.
    PubMed     Abstract available
    
    
    
29. GALE CP, Stocken DD, Aktaa S, Reynolds C, et al
    Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
    BMJ. 2023;381:e073843.
    PubMed     Abstract available
    
    
    May 2023
30. SAMARASEKERA EJ, Clark CE, Kaur S, Patel RS, et al
    Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance.
    BMJ. 2023;381:1028.
    PubMed    
    
    
    March 2023
31. KARAM G, Agarwal A, Sadeghirad B, Jalink M, et al
    Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.
    BMJ. 2023;380:e072003.
    PubMed     Abstract available
    
    
    
32. MORALES DR, Minchin M, Kontopantelis E, Roland M, et al
    Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis.
    BMJ. 2023;380:e072098.
    PubMed     Abstract available
    
    
    
33. LITTLE MP, Azizova TV, Richardson DB, Tapio S, et al
    Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2023;380:e072924.
    PubMed     Abstract available
    
    
    
34. AUVINEN A
    Increased cardiovascular disease risk after exposure to low dose radiation.
    BMJ. 2023;380:e074589.
    PubMed    
    
    
    February 2023
35. CRUMP C, Sundquist J, McLaughlin MA, Dolan SM, et al
    Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study.
    BMJ. 2023;380:e072112.
    PubMed     Abstract available
    
    
    January 2023
36. O'DOWD A
    NICE recommends wider use of statins to cut cardiovascular risk.
    BMJ. 2023;380:p89.
    PubMed    
    
    
    October 2022
37. 
    Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial.
    BMJ. 2022;379:e071133.
    PubMed     Abstract available
    
    
    September 2022
38. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    PubMed     Abstract available
    
    
    
39. YUN I
    Regional inequality in myocardial infarction treatment cannot be blamed on effectiveness of individual cardiologists.
    BMJ. 2022;378:o2235.
    PubMed    
    
    
    
40. DEBRAS C, Chazelas E, Sellem L, Porcher R, et al
    Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Sante cohort.
    BMJ. 2022;378:e071204.
    PubMed     Abstract available
    
    
    June 2022
41. WISE J
    NICE endorses new drug to prevent myocardial infarctions and strokes.
    BMJ. 2022;377:o1444.
    PubMed    
    
    
    
42. AL-LAMEE RK, Foley M, Rajkumar CA, Francis DP, et al
    Revascularization in stable coronary artery disease.
    BMJ. 2022;377:e067085.
    PubMed     Abstract available
    
    
    May 2022
43. LU Y, Melnick ER, Krumholz HM
    Clinical decision support in cardiovascular medicine.
    BMJ. 2022;377:e059818.
    PubMed     Abstract available
    
    
    
44. 
    Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
    BMJ. 2022;377:o1161.
    PubMed    
    
    
    
45. CRAM P, Hatfield LA, Bakx P, Banerjee A, et al
    Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
    BMJ. 2022;377:e069164.
    PubMed     Abstract available
    
    
    
46. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    PubMed     Abstract available
    
    
    
47. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    PubMed     Abstract available
    
    
    April 2022
48. HARSKAMP RE, Fanaroff AC, Zhen SW, Sawe HR, et al
    Recognising acute coronary syndrome.
    BMJ. 2022;377:e069591.
    PubMed    
    
    
    March 2022
49. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    PubMed     Abstract available
    
    
    
50. MAHASE E
    Study questions relationship between statins and cardiovascular outcomes.
    BMJ. 2022;376:o712.
    PubMed    
    
    
    February 2022
51. 
    Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial.
    BMJ. 2022;376:o438.
    PubMed    
    
    
    
52. TANNE JH
    Six in 10 US women have poor cardiovascular health before pregnancy, study finds.
    BMJ. 2022;376:o402.
    PubMed    
    
    
    January 2022
53. 
    P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
    BMJ. 2022;376:o239.
    PubMed    
    
    
    
54. BRUSH JE JR, Sherbino J, Norman GR
    Diagnostic reasoning in cardiovascular medicine.
    BMJ. 2022;376:e064389.
    PubMed     Abstract available
    
    
    November 2021
55. FU EL, Evans M, Carrero JJ, Putter H, et al
    Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
    BMJ. 2021;375:e066306.
    PubMed     Abstract available
    
    
    
56. BELTRAME JF, Tavella R, Jones D, Zeitz C, et al
    Management of ischaemia with non-obstructive coronary arteries (INOCA).
    BMJ. 2021;375:e060602.
    PubMed     Abstract available
    
    
    
57. SAUL H, Gursul D
    Even low doses of steroids increase the risk of cardiovascular disease in people with inflammatory diseases.
    BMJ. 2021;375:n2599.
    PubMed     Abstract available
    
    
    October 2021
58. MAHASE E
    US taskforce advises against low dose aspirin for primary prevention of cardiovascular disease.
    BMJ. 2021;375:n2521.
    PubMed    
    
    
    
59. NAGHSHI S, Aune D, Beyene J, Mobarak S, et al
    Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2021;375:n2213.
    PubMed     Abstract available
    
    
    September 2021
60. GRAY AJ, Roobottom C, Smith JE, Goodacre S, et al
    Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial.
    BMJ. 2021;374:n2106.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.